1. Is stiffness reliable for the detection of liver fibrosis in HCV patients treated with direct acting antiviral drugs (DAAs)? A prospective cohort study. Issue 1 (February 2018) Authors: Gaia, S.; Vanni, E.; Campion, D.; Rolle, E.; Stradella, D.; Valdivia, P. Cortegoso; Evangelista, A.; Ciancio, A.; Smedile, A.; Trapani, R.; Saracco, G.M. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Percutaneous microwave (MW) is superior to radiofrequency ablation (RFA) to induce complete response in cirrhotic patients with very early and early hepatocellular carcinoma (HCC). (February 2019) Authors: Mosso, E.; Ciruolo, M.; Vola, S.; Carucci, P.; Rolle, E.; Risso, A.; Migliore, E.; Saracco, G.M.; Gaia, S. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PH-0499 SABR as a treatment option for HCC patients: efficacy and toxicity profile. (August 2021) Authors: Carlevato, R.; Chiofalo, V.; Spinelli, L.; Giglioli, F.R.; Carucci, P.; Rolle, E.; Rizza, G.; Faletti, R.; Romagnoli, R.; Saracco, G.M.; Fonio, P.; Iorio, G.C.; Guarneri, A.S.; Ricardi, U. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Risk of developing hepatocellular carcinoma (HCC) in patients with cirrhosis of viral etiology evaluated by the association of alpha-fetoprotein (AFP), protein induced by vitamin K absence or antagonist-II (PIVKA-II) and glypican-3 (GPC-3). (February 2020) Authors: Caviglia, G.P.; Abate, M.L.; Ciruolo, M.; Carucci, P.; Olivero, A.; Rolle, E.; Rosso, C.; Younes, R.; Ciancio, A.; Smedile, A.; Saracco, G.M.; Bugianesi, E.; Gaia, S. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Single centre experience with Nivolumab as monotherapy in chirrotic patients with advanced HCC. (March 2023) Authors: Gaia, S.; Frigo, F.; De Giorgi, A.; Caviglia, P.; Rolle, E.; Pochettino, P.; Scaldaferri, M.; Cattel, F.; Risso, A.; Saracco, GM; Carucci, P Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗